Tresiba FlexTouch is a prefilled insulin pen containing insulin degludec, a long-acting basal insulin that provides up to 42 hours of blood glucose-lowering activity. It is designed for once-daily subcutaneous injection and offers consistent insulin release with less day-to-day variability. Tresiba degludec is indicated for:

• Adults and children with type 1 diabetes
• Adults and children with type 2 diabetes who require basal insulin therapy

Tresiba FlexTouch pens are supplied as ready-to-use injection devices, making them convenient for daily use. Tresiba is intended for long-term treatment and should be used regularly under the guidance of a healthcare provider. Tresiba FlexTouch pens are available at Online Pharmacy in the following strengths and package sizes: • 100 U/mL - 5 × 3 mL pens (pack of 5) • 200 U/mL - 3 × 3 mL pens (pack of 3)